(All Comp Data).xlsx - GSK(GLAXO SMITH KLYNE INCOME...

GSK (GLAXO SMITH KLY
INCOME STATEMENT FOR TH
YEAR 2017 2016
Net sales 32,773,770 27,563,533
Cost of sales - 24,095,384 20,099,062
Gross profit 8,678,386 7,464,471
Selling, marketing and distribution expenses - (3,278,792) (2,816,163)
Administrative expenses - (982,786) (944,201)
Operating profit 4,416,808 3,704,107
Other operating expenses - 439,456 372,750
Other income + 1,036,344 1,040,556
EBIT 5,013,696 4,371,913
Financial charges - 88,282 19,032
Profit before taxation EBT 4,925,414 4,352,881
Taxation - 1,898,180 1,707,969
Net Income/Profit for year 3,027,234 2,644,912
Discounted operation :
Loss- OR Profit+ 46,211 117,273
2,981,023 2,762,185
Other comprehensive income :
Remeasurement of staff retirement benefits - 267,816 58,831
Impact of taxation - 72,071 17,258
195,745 41,573
TOTAL COMPREHENSIVE INCOME 2,785,278 2,803,758
Purchases 2,653,726 2,899,150

LYNE)
HE YEAR ENDED
2015 2014 2013
23,821,926 22,843,250 25,230,878
17,397,755 16,996,459 19,002,112
6,424,171 5,846,791 6,228,766
(2,787,942) (2,607,462) (3,625,389)
(971,144) (936,170) (935,974)
- 2,665,085 - 2,303,159 - 1,667,403
255,635 230,783 153,230
1,159,017 488,010 454,916
3,568,467 2,560,386 1,969,089
54,361 20,363 159,217
3,514,106 2,540,023 1,809,872
1,003,380 1,005,105 747,609
2,510,726 1,534,918 1,062,263
132,504 152,153 -
2,643,230 1,687,071 1,062,263
105,995 116,163 81,095
31,781 38,187 27,491
74,214 77,976 53,604
2,717,444 1,609,095 1,008,659
2,465,134 3,400,399 3,498,279

LIQUIDITY RATIOS 2017 2016 2015 2014
Current ratio 1.54 1.68 1.89 1.84
Quick ratio 0.60 0.71 0.73 0.52
ACTIVITY RATIOS/EFFECIENCY RATIOS/TURNOVER
Recievable turnover ratio 22.66 64.15 55.14 51.62
Days sales outstanding 16.11 5.69 6.62 7.07
Payable turnover ratio 3.74 3.49 3.09 2.94
Days in payable 97.51 104.44 118.10 124.17
Inventory turnover ratio 4.00 3.79 3.07 2.64
Days inventory in hand 91 96 119 138
Total Asset turnover 1.52 1.34 1.21 1.23
PROFITABILITY RATIOS
Gross profit margin 26% 27% 27% 26%
Operating profit margin 13% 13% 11% 10%
Net profit margin 9% 10% 11% 7%
Return on Assets (ROA)
Return on equity (ROE) 22% 20% 20% 13%
SOLVENCY RATIOS
Debt to equity 62% 56% 54% 60%
Debt to capital 38% 36% 35% 37%
Debt to asset 38% 36% 35% 37%
Interest coverage 56.79 229.71 65.64 125.74

2013
1.91
0.43
72.10
5.06
3.42
106.83
2.96
123
1.41
25%
7%
4%
9%
58%
37%
37%
12.37

BALANCE SHEET FOR THE YEAR ENDED
YEAR 2,017 2,016 2,015
ASSETS
Non Current Assets
Fixed assets 8,865,334 8,318,434 7,154,446
Intangibles 1,039,072 1,039,072 1,039,072
Long-Term loans to employees 91,422 49,369 49,212
Long-Term deposits 22,204 21,955 21,955
10,018,032 9,428,830 8,264,685
Current Assets
Stores and spares 219,613 201,037 158,564
Stock-in-trade 6,082,218 5,548,083 4,707,918
Trade debts 2,362,703 530,413 328,948
Loans and advances 453,116 177,653 340,491
Trade deposits and prepayments 131,920 134,335 123,223
Interest accured 3,182 12,074 10,908
Refunds due from government 30,113 54,178 109,125
Other receivables 251,325 484,945 313,127
Taxation - payments less provisions - - 531,579
Investments 348,810 793,873 695,586
Cash and bank balances 1,818,900 3,515,638 2,946,612
11,701,900 11,452,229 10,266,081